WWARN’s extensive scientific work has informed changes in dosage and combinations of antimalarial drugs and has led to policy change. 

IDDO Researchers presented at the European CDISC Interchange held in Amsterdam, Netherlands from May 6 to 7, 2019.

A letter signed by IDDO, members of the Chagas Platform and the Chagas Global Coalition calling on governments, organisations and donors to intensify efforts to control and eliminate Chagas has been presented to the World Health Organization (WHO).

IDDO and WWARN's Clinical Scientific Group have published research in BMC Medical Research Methodology comparing different statistical approaches for deriving cumulative estimates of drug efficacy from clinical studies. Results indicate that the Cumulative Incidence Function (CIF) approach should be...

The Ebola Data Platform, a pioneering collaboration in Ebola and emerging infections, has today appointed nine members for its first Data Access Committee (DAC), overseen and chaired by TDR, the Special Programme for Research and Training in Tropical Diseases, hosted at WHO.

La plateforme de données Ebola, une collaboration pionnière dans le domaine d'Ebola et des infections émergentes, a nommé aujourd'hui neuf membres à son premier Comité d'accès aux données (CAD), supervisé et présidé par le TDR, le Programme spécial de recherche et de formation sur les maladies tropi...

IDDO has published a Draft Research Agenda for open review on visceral leishmaniasis (VL) for feedback and comments from the wider VL research community. The deadline for comments is 5 July 2019.

Professor Joel Tarning, Head of Clinical Pharmacology at MORU, and Head WWARN’s Pharmacometrics Group will present highlights on population PK/PD modelling to assess the dosing of antimalarial drugs in vulnerable groups. Dr Makoto Saito will share highlights from his research on antimalarial treatme...

Research collaboration maps close to 10,000 samples on molecular markers surveyor, in near real-time.

IDDO's Director Philippe Guerin and colleagues have recently published a framework for the reporting and interpretation of clinical microbiology data in BMC Medicine. Read the research.

Malaria is still a global health burden, despite numerous coordinated efforts for eradication. One obstacle to eradication is the malaria parasite’s quick adaptation to anti-malarial drugs resulting in drug resistance. Resistance mechanisms are ill understood for many antimalarials, making it diffic...

A Ki Data Challenge has been launched by Grand Challenges Africa (GCA) - a programme of the African Academy of Sciences (AAS) supported through the AAS funding and programmes implementation platform, the Alliance for Accelerating Excellence in Science in Africa (AESA) - and the African Academy of Sc...

Widely used malaria treatment to prevent malaria in pregnant women at risk of failing in areas where drug resistance is rising.

Rob van der Pluijm presents findings from the Tracking Resistance to Artemesinin Collaboration II programme, which looks at the further extension of drug resistant malaria in Southeast Asia, and the innovative analyses of Triple artemisinin combination therapies (TACTs). Latest news of the launch pl...

A White Blood Cell (WBC) Count in Malaria Study group aims to identify what determines WBC count during baseline and acute phase of malaria infection.

A Haemoglobin-Haematocrit Relationship in Malaria Study Group is assessing the accuracy of estimating haemoglobin (Hb) levels from haematocrit (Hct) levels. The aim is to use this analysis to derive a more robust formula for converting Hct to Hb levels to improve anaemia diagnosis in malaria.

The Royal Society of Tropical Medicine and Hygiene (RSTMH) small grants programme is now open.

Paul Sondo is a molecular parasitologist from the Clinical Research Unit of Nanoro in Burkina Faso. Paul spent the last 12 months with WWARN as a recipient of the Clinical Research and Development Fellowship (CRDF), jointly implemented by TDR*, the Special Programme for Research and Training in Trop...

A recent article published in Malaria Journal by members of the WWARN Molecular Scientific and Informatics Group describes the development of WWARN’s ACT Partner Drug Molecular Surveyor. Launched in 2015, this online mapping tool supports the malaria community to track over nearly 20 years the preva...

Today IDDO has launched a new global scientific collaboration dedicated to schistosomiasis and STHs with TDR (the Special Programme for Research and Training in Tropical Diseases). This aims to expand data re-use and collaboration and accelerate better treatment and control of these diseases, which ...